Guidance on pregabalin and gabapentin becoming CDs published

Community pharmacy teams are reminded that from 1st April 2019 pregabalin and gabapentin will be reclassified as Schedule 3 Controlled Drugs...

Book now for PSNC’s Price Concessions Webinar

Mike Dent (Director of Pharmacy Funding) and Suraj Shah (Drug Tariff and Reimbursement Manager) will be hosting a PSNC webinar about...

Class 2 MHRA Medicines Recall: Irbesartan / Hydrochlorothiazide (Actavis Group PTC EHF)

Drug alert number: EL (19) A/04 Date issued: 13th February 2019 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued...

Pregabalin & gabapentin – prescribing by EMIS GP practices

Changes to general practice clinical systems will have to be made ahead of 1st April 2019, when pregabalin and gabapentin...